retatrutide effects clinical trials Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Today's TRIUMPH-4 results are a

GLP-1 medications alter intestinal motility and secretion, causing diarrhea in some users

Most diabetic patients (61.2%) exhibited poor glycemic control

Here's what the research shows, what's legal, and what to do right now while it's still in trials.

Discover the truth about GLP-1 receptor agonists, their Gila monster origins, modern manufacturing methods, and UK safety regulations for diabetes and weight management.

In animal models of diabetes, the authors show that co-administration of a lipid-lowering drug with a dipeptidyl peptidase-4 inhibitor or a glucagon-like peptide-1 agonist improved glucose tolerance and beta cell mass

Ozempic needs to be refrigerated until youre ready to use it